ABM-300

N/A

Report date: 2025/01/26 15:12:12
NME

Base Information

Drug NameABM-300
Drug Alias Namecannabinoid receptor 1 negative allosteric modulator (University of Toronto/University of Aberdeen)ABM-300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Toronto
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of TorontoUniversity Of Aberdeen
Inactive CompaniesN/A
Active IndicationsMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A